Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 14Unknown 4Recruiting 2Not yet recruiting 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Psychological Well-Being 1Parasomnias 1Fatigue 1Breast Neoplasms 1

Interventions

pembrolizumab 437Carboplatin 322Nivolumab 292Cyclophosphamide 281Specimen Handling 271Magnetic Resonance Spectroscopy 257Cisplatin 253Paclitaxel 248Radiotherapy 229Gemcitabine 183Biopsy 182Dexamethasone 181durvalumab 168atezolizumab 151Rituximab 138Doxorubicin 135Lenalidomide 134Bevacizumab 133Docetaxel 131Ipilimumab 129Capecitabine 120Radiation 118Oxaliplatin 114Radiosurgery 113Pemetrexed 112Etoposide 111Fluorouracil 110venetoclax 106fludarabine 106Prednisone 97

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Relaxation Therapy × Clear all
NCT01202851 2026-05-05

Relaxation for Women With Breast Cancer Undergoing Radiotherapy

M.D. Anderson Cancer Center

Phase 3 Active not recruiting
681 enrolled
Breast

Psychological Well-Being, Breast Neoplasms, Fatigue, Parasomnias

Data powered by HemOnc (CC BY 4.0) Colophon âš¡